Pacira Pharmaceuticals buy Truist Financial Co.
Start price
17.08.26
/
50%
€19.90
Target price
17.08.27
€25.91
Performance (%)
2.51%
Price
19.08.26
€20.40
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ shows slight gains of 2.51%. This prediction currently runs until 17.08.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pacira Pharmaceuticals | 2.51% |
| iShares Core DAX® | -1.059% |
| iShares Nasdaq 100 | -2.387% |
| iShares Nikkei 225® | -4.361% |
| iShares S&P 500 | -1.778% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences (PCRX) is now covered by Truist Financial Corporation. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€19.10
07.11.25
07.11.25
€24.27
07.11.26
07.11.26
9.95%
19.08.26
19.08.26
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€18.90
25.07.25
25.07.25
€25.55
25.07.26
25.07.26
20.63%
26.07.26
26.07.26
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€18.40
25.07.24
25.07.24
€27.62
25.07.25
25.07.25
2.17%
26.07.25
26.07.25